The U.S. Food and Drug Administration (FDA) has published a proposal to expand the list of permitted active ingredients in over-the-counter (OTC) sunscreens in the United States. This initiative is part of the agency's efforts to update the regulatory framework for sun protection and evaluate UV filters with a proven track record of use in other international markets.

The US Food and Drug Administration (FDA) has published a report, required by Congress under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), evaluating the use of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in cosmetic products marketed in the United States.

British authorities have notified the World Trade Organization (WTO) of a proposed amendment to the cosmetics regulations applicable in Great Britain, which introduces significant changes regarding ingredients. The amendment affects both the restriction of certain substances and the expansion of the list of ingredients prohibited by their CMR classification.

Canada has confirmed the phased introduction of new fragrance allergen labeling requirements for cosmetic products, a change relevant to all brands that operate or want to operate in this market.

This regulatory move is part of a broader FDA effort to modernize the monograph system for over-the-counter drugs—including sunscreens—and promote scientific innovation in sun protection formulations. Although the proposal remains open for public comment until January 2026, its progress has already generated interest among formulators and dermatologists, who see bemotrizinol as a tool for delivering more effective formulations with an improved sensory profile.

The EPA proposes changes to the PFAS reporting rule under TSCA in the US, introducing exemptions and shorter deadlines. Comments open until December 2025.